Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis-Reference-Cited by-同舟云学术

Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis

Published:2021-09-02 Issue:11 Volume:41 Page:1925-1931
ISSN:0172-8172
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Bartels Lars Erik^ORCID,Ammitzbøll Christian^ORCID,Andersen Jakob Bøgh^ORCID,Vils Signe Risbøl^ORCID,Mistegaard Clara Elbæk^ORCID,Johannsen Anders Dahl^ORCID,Hermansen Marie-Louise From^ORCID,Thomsen Marianne Kragh^ORCID,Erikstrup Christian^ORCID,Hauge Ellen-Margrethe^ORCID,Troldborg Anne^ORCID

Funder

gigtforeningen

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s00296-021-04972-7.pdf

Reference12 articles.

1. Curtis JR, Johnson SR, Anthony DD et al (2021) American College of Rheumatology Guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases—version 1. Arthritis Rheumatol. https://doi.org/10.1002/art.41734

2. Bower H, Frisell T, Di Giuseppe D et al (2021) Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study. Ann Rheum Dis. https://doi.org/10.1136/ANNRHEUMDIS-2021-219845

3. Ammitzbøll C, Andersen JB, Vils SR et al (2021) Isolation, behavioral changes and low seroprevalence of SARS-CoV-2 antibodies in patients with systemic lupus erythematosus or rheumatoid arthritis. Arthritis Care Res (Hoboken). https://doi.org/10.1002/ACR.24716